Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cobalt's Altace Generic Gets FDA Approval, 180 Days Of Exclusivity

Oct 25 2005

• By Jessica Merrill

Related Content

Altace Will Provide "Stable" Growth Platform For Three Years, King Says

Apr 12 2005

Altace Will See Challenge From Generic ACE Inhibitors, Not Class Labeling, King Says

May 09 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window